#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Hepatocellular carcinoma Dementia Alzheimer's type Dermatitis atopic Asthma Breast cancer metastatic Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Activated PI3 kinase delta syndrome Small cell lung cancer recurrent Chronic graft versus host disease in liver X-linked lymphoproliferative syndrome Retinal artery occlusion Netherton's syndrome Colorectal cancer metastatic Fontan procedure Frostbite Arterial tortuosity syndrome Ureteric cancer Malignant oligodendroglioma Congenital pseudarthrosis Cytomegalovirus infection Gestational trophoblastic tumour More trials…

    Learn about Rare Diseases

    Activated PI3 kinase delta syndrome – Diagnostics Rosai-Dorfman syndrome – Life with Disease Cystic fibrosis Soft tissue sarcoma – Basic Information Piriformis syndrome – Trials in Disease Congenital generalised lipodystrophy – Basic Information Leiomyosarcoma metastatic – Trials in Disease Vascular malformation – Treatment Mucous membrane pemphigoid – Basic Information Systemic sclerosis pulmonary – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sulfamethizole Vafidemstat Ibuprofen Perampanel Dexamethasone Acetate Ph. Eur. Itacitinib Sodium Lactate Leflunomide Nomegestrol Acetate ALE.P02 Pegcetacoplan Aluminium Hydroxide Human Coagulation Factor Viii Vemurafenib D,L-Lysine Acetylsalicylate Rimegepant Corifollitropin Alfa Rotigotine Edotreotide GSK5458514 More therapies…

    Learn about Your Condition

    High-grade B-cell lymphoma Herpes simplex meningitis Nervous system disorder Squamous cell carcinoma Chronic granulomatous disease Dementia Alzheimer's type Supraventricular tachycardia Neonatal anoxia Mite allergy Cirrhosis alcoholic Ovarian granulosa cell tumour Pseudoxanthoma elasticum Rabies Tuberous sclerosis complex Transient ischaemic attack More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiomyopathy

  • A Study Comparing Gadopiclenol and Gadoterate Meglumine for Heart MRI Scans in Children with Congenital Heart Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Meglumine Gadoterate
    Spain

  • A study testing ninerafaxstat compared to placebo in patients with symptomatic non-obstructive hypertrophic cardiomyopathy

    Recruiting

    2 1
    Investigated Diseases:
    • Cardiomyopathy
    • Hypertrophic cardiomyopathy
    Austria Belgium France Germany Italy The Netherlands +3

  • Study of stopping heart failure medications in patients with non-ischemic cardiomyopathy who responded very well to cardiac resynchronization therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Altizide
    • Atenolol
    • Captopril
    Spain

  • Study of Nucresiran in Adults with Transthyretin Amyloidosis with Cardiomyopathy to Evaluate its Effects on Survival and Heart Problems

    Recruiting

    3 1
    Investigated Diseases:
    • Cardiomyopathy
    Austria Belgium Czechia Denmark France Germany +12

  • Study on Valsartan and Sacubitril for Preventing Disease Progression in Patients with Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Sacubitril
    • Valsartan
    Poland

  • Study on Colchicine for Treating Patients with Inflammatory Cardiomyopathy

    Not yet recruiting

    3 1 1
    Investigated Diseases:
    • Cardiomyopathy
    Investigated Drugs:
    • Colchicine
    Italy
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!